These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 18006853)

  • 1. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
    Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.
    Hsu YM; Chou CY; Chen HH; Lee WY; Chen YF; Lin PW; Alper SL; Ellory JC; Shen MR
    J Cell Physiol; 2007 Mar; 210(3):626-36. PubMed ID: 17133354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; RosanĂ² L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the stability of cell surface E-cadherin by the proteasome.
    Saitoh M; Shirakihara T; Miyazono K
    Biochem Biophys Res Commun; 2009 Apr; 381(4):560-5. PubMed ID: 19245796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F; Behrens J
    Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin regulates the association between beta-catenin and actinin-4.
    Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T
    Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
    Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
    Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
    Yuan Z; Wong S; Borrelli A; Chung MA
    Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
    Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM
    FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
    Kim K; Daniels KJ; Hay ED
    Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
    Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.